Ritz B. 1999. Radiation exposure and cancer mortality in uranium processing workers. Epidemiology 10(5):531–538.

Ross RJ, Tsagarakis S, Grossman A, Nhagafoong L, Touzel RJ, Rees LH, Besser GM. 1987. GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: Studies with pyridostigmine and GHRH. Clin Endocrinol (Oxf) 27(6):727–733.


Somani SM. 1992. Chemical Warfare Agents. New York: Academic Press.

Stewart CE, Sullivan J Jr. 1992. Military munitions and antipersonnel agents. In: Sullivan JB Jr, Krieger G, eds. Hazardous Materials Toxicology: Clinical Principles of Environmental Health. Baltimore: Williams & Wilkins. Pp. 986–1014.


Unwin C, Blatchley N, Coker W, Ferry S, Hotopf M, Hull L, Ismail K, Palmer I, David A, Wessely S. 1999. Health of UK servicemen who served in Persian Gulf War. Lancet 353(9148):169–178.

USAMRIID (U.S. Army Medical Research Institute of Infectious Diseases). 1996. Medical Management of Biological Casualties: Handbook. 2nd edition. Fort Detrick, MD: USAMRIID.


White CS, Adler WH, McGann VG. 1974. Repeated immunization: Possible adverse effects. Ann Intern Med 81(5):594–600.

Williams, JI. 1984. Human Response to Pyridostigmine Bromide. Fairborn, OH: Macaulay-Brown, Inc. (Available from the National Technical Information Service: NTIS/ AD-A140960.)


Yang I, Woo J, Kim S, Kim J, Kim Y, Choi Y. 1995. Combined pyridostigmine–thyrotrophin-releasing hormone test for the evaluation of hypothalamic somatostatinergic activity in healthy normal men. Eur J Endocrinol 133(4):457–462.


Zamora ML, Tracy BL, Zielinski JM, Meyerhof DP, Moss MA. 1998. Chronic ingestion of uranium in drinking water: A study of kidney bioeffects in humans. Toxicol Sci 43(1):68–77.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement